Lobbying Activity Report


Organization: MERCK CANADA INC.
Associated registration: 8265-2093-31
Lobbying Activity date: 2022-10-12
Arranged a meeting: No
Posted date: 2022-11-15

In-house lobbyists who participated in the lobbying activity: Lonnie Kam
Senior Public Office Holders who were lobbied in this activity: Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Engage BC government on Merck’s commercial product/asset pipeline and seek access listing agreements.
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity
Senior officer who filed this Lobbying Activity Report: Marwan Akar
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Date Modified: